Figure 2
Figure 2. Event-free survival during 5 years of follow-up in patients with ALL, according to the type of postinduction chemotherapy.

Event-free survival during 5 years of follow-up in patients with ALL, according to the type of postinduction chemotherapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal